- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: ADT Docetaxel Enzalutamide
Total 6904 results
-
Novartis PharmaceuticalsAlliance Foundation Trials, LLC.; RTOG Foundation, Inc.Active, not recruitingProstatic NeoplasmsUnited States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
-
AbbottTerminatedNon-Small Cell Lung Cancer | Lung CancerUnited States, Canada, Ireland, United Kingdom
-
Nereus Pharmaceuticals, Inc.CompletedCancerUnited States, Australia, India, Chile, Brazil, Argentina
-
VZW Cardiovascular Research Center AalstAZ Sint-Jan AVUnknown
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)TerminatedClear Cell Renal Cell Carcinoma | Stage I Renal Cell CancerUnited States
-
Santa Chiara HospitalUnknownProstatic NeoplasmsItaly
-
Eli Lilly and CompanySarah Cannon Development InnovationsCompletedProstate Cancer MetastaticUnited States
-
Memorial Sloan Kettering Cancer CenterAstellas Pharma Inc; Medivation, Inc.Active, not recruitingBreast Cancer | Triple Negative Breast Cancer | Early StageUnited States
-
Progenics Pharmaceuticals, Inc.Active, not recruitingCastration-resistant Prostate Cancer | Metastatic Prostate Cancer | Cancer of the Prostate | Prostatic Neoplasm | Progressive mCRPCUnited States, Canada
-
BayerCompletedCerebrovascular CirculationUnited Kingdom
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerChina
-
Karolinska InstitutetThe Swedish Research Council; AstraZeneca; Janssen Pharmaceutica N.V., Belgium; Kom Op Tegen Kanker and other collaboratorsRecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC) | Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)Sweden, Belgium, Switzerland, Norway
-
Fudan UniversityUnknown
-
Merck Sharp & Dohme LLCActive, not recruitingMetastatic Hormone-Sensitive Prostate CancerTaiwan, Poland, United States, Australia, Austria, Brazil, Canada, Chile, China, Colombia, Denmark, Finland, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Netherlands, New Zealand, Peru, Russian Federation, Spai... and more
-
Academy Military Medical Science, ChinaCancer Institute and Hospital, Chinese Academy of Medical SciencesUnknown
-
TakedaTakeda Development Center Americas, Inc.RecruitingAlpha1-Antitrypsin DeficiencyUnited States, Belgium, Switzerland, Canada, Australia, Germany, United Kingdom, Austria, France, Spain, Portugal, Italy, Poland
-
Japan Clinical Oncology GroupMinistry of Health, Labour and Welfare, JapanCompletedBreast Cancer | Neoplasm MetastasisJapan
-
AbbVie (prior sponsor, Abbott)CompletedAdvanced Solid Tumors
-
Otsuka Pharmaceutical Development & Commercialization...CompletedMajor Depressive DisorderUnited States
-
University of WashingtonRecruitingRecurrent Mantle Cell Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Recurrent B-Cell Non-Hodgkin Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | Post-Transplant Lymphoproliferative Disorder | Refractory Mantle Cell Lymphoma | Recurrent Follicular... and other conditionsUnited States
-
Samsung Medical CenterActive, not recruiting
-
Jiangsu Alphamab Biopharmaceuticals Co., LtdActive, not recruitingMetastatic Breast CancerChina
-
Tianjin Medical University Cancer Institute and...Recruiting
-
Swiss Group for Clinical Cancer ResearchTerminatedProstate Cancer | Cancer of the ProstateSwitzerland
-
OHSU Knight Cancer InstituteUnited States Department of Defense; Oregon Health and Science UniversityCompletedCastration-Resistant Prostate Carcinoma | Prostate Adenocarcinoma | Recurrent Prostate Carcinoma | Stage IV Prostate Cancer | PSA Progression | Castration Levels of TestosteroneUnited States
-
Arcus Biosciences, Inc.Gilead SciencesActive, not recruitingProstatic Neoplasms, Castration-Resistant | Prostatic Cancer, Castration-Resistant | Castration Resistant Prostatic Neoplasms | Androgen-Resistant Prostatic NeoplasmsUnited States, Canada
-
National Cancer Center, KoreaSeoul National University Bundang Hospital; Gachon University Gil Medical Center and other collaboratorsUnknownGastric CancerKorea, Republic of
-
Zhuhai Beihai Biotech Co., LtdCompletedSolid Tumours | Bioequivalence | DocetaxelIndia
-
Jiangsu HengRui Medicine Co., Ltd.Shanghai Pulmonary Hospital, Shanghai, ChinaCompletedNon-Small Cell Lung Cancer (NSCLC)China
-
AbbVieCompletedAdvanced Solid TumorsJapan
-
The Affiliated Nanjing Drum Tower Hospital of Nanjing...RecruitingNeoadjuvant Therapy | High Risk Prostate Cancer | Locally Advanced Prostate Cancer | Intense Endocrine TherapyChina
-
Optimal Health ResearchCompletedBreast Cancer | Lung Cancer | Prostate CancerUnited States
-
National Cancer Institute (NCI)RecruitingEGFR-Mutated Non-Small-Cell Lung Carcinoma | Small Cell/NeuroendocrineUnited States
-
PfizerCompletedMetastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)Finland
-
Changhai HospitalRecruiting
-
San Diego State UniversityNational Institute of Mental Health (NIMH)Completed
-
Hoffmann-La RocheCompletedProstatic Neoplasms, Castration-ResistantUnited States, Korea, Republic of, Belgium, United Kingdom, Canada, China, Denmark, France, Greece, Poland, Spain, Italy, Czechia, Japan, Switzerland, Australia, Germany, Austria, Hungary, Russian Federation, Taiwan
-
DendreonCompletedMetastatic Prostate CancerUnited States
-
Emergent BioSolutionsWalter Reed Army Institute of Research (WRAIR)TerminatedAdenoviral InfectionUnited States
-
Jena University HospitalBayerRecruitingMetastatic Hormone-Sensitive Prostate Cancer (mHSPC)Germany
-
Arog Pharmaceuticals, Inc.WithdrawnCarcinoma, Non-Small-Cell Lung
-
First People's Hospital of FoshanUnknown
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungJapan
-
Asan Medical CenterUnknownCastration-resistant Prostate CancerKorea, Republic of
-
SanofiCompleted
-
Astellas Pharma Global Development, Inc.Medivation LLC, a wholly owned subsidiary of Pfizer Inc.CompletedAdvanced Breast Cancer | HER2 Amplified | Human Epidermal Growth Factor Receptor 2 (HER2)United States, Belgium, Canada, Italy, Spain, United Kingdom
-
SanofiCompletedLung NeoplasmsFrance, Netherlands, Spain, Turkey, Belgium, Finland, Italy, United Kingdom
-
NantCell, Inc.CompletedBreast Cancer | Pancreatic Cancer | Ovarian Cancer | Lung Cancer | Colon Cancer | Thyroid CancerUnited States
-
Vanderbilt-Ingram Cancer CenterNational Cancer Institute (NCI); Genentech, Inc.; Translational Breast Cancer... and other collaboratorsTerminatedStage IV Breast Cancer | Estrogen Receptor Negative | Estrogen Receptor Positive | HER2/Neu Negative | Progesterone Receptor Negative | Progesterone Receptor Positive | Triple-Negative Breast CarcinomaUnited States